Numinus Wellness Inc (OP: LKYSF )
1.171 USD UNCHANGED Streaming Delayed Price Updated: 3:59 PM EST, Jan 25, 2021 Add to My Watchlist
Stories about Numinus Wellness Inc
The latest news and YTD performances of the 30 stocks in the fledgling but burgeoning pure-play psychedelic bio-pharmaceutical drug stocks sector.
Penny Stocks To Watch As New Psychedelic ETF Launches This Week
January 25, 2021
Tags Market News
Psychedelics Revolution Gaining Breadth And Momentum
January 25, 2021
As investment capital floods into the psychedelics sector, psychedelic drug companies are rapidly building out an industry – vertically and horizontally.
New Psychedelics ETF Is Another Sector Milestone
January 05, 2021
The first psychedelic stock ETF is about to commence trading. Yet another milestone for an emerging industry with a very bright future.
Psychedelic Stocks Index: +58.4% In December
January 02, 2021
As these companies continue to appreciate, we expect to see some be appreciated - and bought out - by big pharma.
The Year In Review For Psychedelic Drug Stocks: 2020
December 24, 2020
In 2020, the psychedelic drug industry burst onto the radar of investors. As psychedelic drug research exploded and new capital has flooded into this sector, a vibrant core of public companies has...
Have Psychedelics Become The Next Neuroscience Biotech Frontier?
December 22, 2020
Mind Cure was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The world is ...
Will Psychedelic Stocks Be The New ESG Favorites For 2021?
December 18, 2020
For socially-conscious investors, psychedelic drug stocks are very strong candidates for ESG investing.
How Psychedelic Drug Stocks Took Off In 2020
December 17, 2020
Psychedelic Stocks Index Bounced Back On Wednesday
December 17, 2020
31 biopharmaceutical companies are involved in the research and development of psychedelic compounds to treat mental health issues.
Psychedelic Stocks Index Sank 15.9% On Tuesday
December 16, 2020
31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues and this article tracks the performance of 15 of them in the new...
Psychedelic Stocks Index Soared 27% On Monday
December 15, 2020
31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues. 15 of them are constituents in the Psychedelic Stocks Index and...
Psychedelic Stocks Index Took Off Last Week, Gaining 35.3%
December 13, 2020
4 Magic Mushroom Stocks You Might’ve Missed In December 2020
December 11, 2020
Rotation Opportunity As Three Top Psychedelic Stocks Explode
December 10, 2020
With its first psychedelic-assisted treatment clinic preparing to open, Mind Cure Health is an undervalued rotation target.
The Psychedelic Stocks Index Was UP +11% Again Last Week
December 07, 2020
31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds.
Psychedelic Stocks Really Took Off Last Week
November 29, 2020
Thirty-one bio-pharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues.
The New Psychedelic Stocks Index Declined 5.4% This Past Week
November 22, 2020
This article tracks the weekly performance of 11 of 31 stocks involved in the research and development of psychedelic compounds to treat mental health issues such as OCD, PTSD, opioid and alcohol...
We explain why psychedelic drug stocks are surging on news that Oregon has legalized psilocybin for medicinal use.
Medicinal Mushroom Stock Index: Performance Hardly "Magical" Last Week
November 04, 2020
Research into the use of mushrooms in the treatment of mental health issues (PTSD, opioid/alcohol addiction, depression, anxiety, eating disorders) suggests that the medicinal mushroom industry is...
Treatment of a host of mental issues using magic mushrooms is on the threshold of becoming the next billion-dollar industry. The industry is in its infancy with 12 companies, as identified below,...
Volatility Reigns In New Medicinal Mushroom Stocks Index
October 28, 2020
Treatment of depression, anxiety, and addiction health issues using either functional (i.e. edible) or psychedelic (i.e. magic) mushrooms could become the next billion-dollar industry and this...
The 4 Best-Performing Psychedelic Stocks
October 26, 2020
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
Introducing The "Medicinal Mushroom" Stock Index
October 23, 2020
The enormous potential of medicines based on edible (functional) mushrooms and magic (psychedelic) mushrooms to treat depression, anxiety and addiction health issues has some whispering that...
Will Mindmed Nasdaq Listing Be The Next Sector-Wide Catalyst?
October 19, 2020
The Compass Pathways IPO sparked a new rally in psychedelic stocks. We expect similar dynamics if MindMed up-lists on the Nasdaq.
The 8 Best Reasons To Invest In Psychedelic Stocks
October 15, 2020
An acute need. Huge markets. A wide-open playing field. These are just some of the best reasons for investing in psychedelic stocks.
3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2